EGFR and lung adenocarcinoma: We have applied this calibration strategy to a mechanistic multiscale KBM of lung adenocarcinoma harboring specific EGFR mutations, and focused on the calibration of tumor growth parameters based on in vitro experiments and xenografted mice.